NovoCure Limited

NASDAQ:NVCR

18.57 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 150.356138.503133.784127.321126.051122.182128.429130.998140.866137.547133.213133.606133.517134.695143.953132.66115.925101.82899.23492.06286.71373.30969.67464.75661.51452.12553.66150.10938.37634.8830.24221.67417.91913.05312.3838.9536.5435.2083.8014.3744.1223.193
Cost of Revenue 34.65433.68932.55632.09234.01829.61428.88829.74928.50327.72729.68730.20628.59926.38528.13628.39525.47424.49624.78622.921.10619.81423.02818.94919.83318.23815.6415.15313.15211.66410.97311.11816.2097.9826.3045.6594.753.8972.632.5862.5432.268
Gross Profit 115.702104.814101.22895.22992.03392.56899.541101.249112.363109.82103.526103.4104.918108.31115.817104.26590.45177.33274.44869.16265.60753.49546.64645.80741.68133.88738.02134.95625.22423.21619.26910.5561.715.0716.0793.2941.7931.3111.1711.7881.5790.925
Gross Profit Ratio 0.770.7570.7570.7480.730.7580.7750.7730.7980.7980.7770.7740.7860.8040.8050.7860.780.7590.750.7510.7570.730.6690.7070.6780.650.7090.6980.6570.6660.6370.4870.0950.3880.4910.3680.2740.2520.3080.4090.3830.29
Reseach & Development Expenses 54.95551.59854.30853.62355.42759.70454.8251.95657.07542.23456.93148.14150.31545.91644.00232.81829.91825.27123.74118.76619.45417.04215.03413.07411.36211.10410.0489.2739.3719.4118.47110.23311.31811.44510.84510.21112.7659.92711.199.27610.3899.526
General & Administrative Expenses 37.71139.5339.44841.88740.77841.94438.0732.50931.66630.50831.01131.23132.7631.12528.36427.06125.40426.60823.75122.71121.24920.23819.06818.85518.20817.32516.45415.21515.02312.42212.99712.72313.03112.25611.1168.4057.3686.9758.2525.0335.9564.811
Selling & Marketing Expenses 56.61655.20659.18857.96458.48851.16949.62941.39544.7537.88438.98232.5834.13831.35731.35929.36428.46128.83426.80423.8323.70822.33321.20819.12419.19618.13516.02516.38716.3614.75615.67815.86514.59813.30814.7248.9168.8666.3554.7385.3846.4734.582
SG&A 94.35494.73698.63699.85199.26693.11387.69973.90476.41668.39269.99363.81166.89862.48259.72356.42553.86555.44250.55546.54144.95742.57140.27637.97937.40435.4632.47931.60231.38327.17828.67528.58827.62925.56425.8417.32116.23413.3312.9910.41712.4299.393
Other Expenses 000000000000000000000000000000000000000000
Operating Expenses 149.309146.334152.944153.474154.693152.817142.519125.86133.491110.626126.924111.952117.213108.398103.72589.24383.78380.71374.29665.30764.41159.61355.3151.05348.76646.56442.52740.87540.75436.58937.14638.82138.94737.00936.68527.53228.99923.25724.1819.69322.68919.167
Operating Income -33.607-41.52-51.716-58.245-62.66-60.249-42.978-24.611-21.128-0.806-23.398-8.552-12.295-0.08812.09215.0226.668-3.3810.1523.8551.196-6.118-8.664-5.246-7.085-12.677-4.506-5.919-15.53-13.373-17.877-28.265-37.237-31.938-30.606-24.238-27.206-21.946-23.009-17.905-21.239-17.994
Operating Income Ratio -0.224-0.3-0.387-0.457-0.497-0.493-0.335-0.188-0.15-0.006-0.176-0.064-0.092-0.0010.0840.1130.058-0.0330.0020.0420.014-0.083-0.124-0.081-0.115-0.243-0.084-0.118-0.405-0.383-0.591-1.304-2.078-2.447-2.472-2.707-4.158-4.214-6.053-4.094-5.153-5.635
Total Other Income Expenses Net 10.8789.87813.18210.0238.7569.16910.421.194-2.228-1.709-2.175-1.981-0.94-2.646-3.267-3.983-2.617-2.432-1.745-2.555-1.239-2.371-2.16-2.397-2.86-4.853-2.384-2.156-2.183-2.446-2.854-2.189-0.555-0.549-0.874-0.809-0.876-0.591-0.053-0.053-0.029-0.018
Income Before Tax -22.729-31.642-38.534-48.222-53.904-51.08-32.558-23.417-23.356-2.515-25.573-10.533-13.235-2.7348.82511.0394.051-5.813-1.5921.3-0.043-8.489-10.824-7.643-9.945-17.53-6.89-8.075-17.713-15.819-20.731-30.454-37.792-32.487-31.48-25.047-28.082-22.537-23.062-17.958-21.268-18.012
Income Before Tax Ratio -0.151-0.228-0.288-0.379-0.428-0.418-0.254-0.179-0.166-0.018-0.192-0.079-0.099-0.020.0610.0830.035-0.057-0.0160.014-0-0.116-0.155-0.118-0.162-0.336-0.128-0.161-0.462-0.454-0.686-1.405-2.109-2.489-2.542-2.798-4.292-4.327-6.067-4.106-5.16-5.641
Income Tax Expense 10.6467.1188.5451.2633.5141.9814.7453.1590.6522.1320.8852.5911.4061.3943.9081.7552.396-9.765-5.852-0.631.2273.6614.8074.0515.5653.1944.0553.4233.4612.2261.4373.1742.822.951.4480.9761.2750.736-0.1460.3620.0590.107
Net Income -33.375-38.76-47.079-49.485-57.418-53.061-37.303-26.576-24.008-4.647-26.458-13.124-14.641-4.1284.9179.2841.6553.9524.261.93-1.27-12.15-15.631-11.694-15.51-20.724-10.945-11.498-21.174-18.045-22.168-33.628-40.612-35.437-32.928-26.023-29.357-23.273-22.916-18.32-21.327-18.119
Net Income Ratio -0.222-0.28-0.352-0.389-0.456-0.434-0.29-0.203-0.17-0.034-0.199-0.098-0.11-0.0310.0340.070.0140.0390.0430.021-0.015-0.166-0.224-0.181-0.252-0.398-0.204-0.229-0.552-0.517-0.733-1.552-2.266-2.715-2.659-2.907-4.487-4.469-6.029-4.188-5.174-5.675
EPS -0.31-0.36-0.44-0.46-0.54-0.5-0.36-0.25-0.23-0.045-0.25-0.13-0.14-0.040.050.090.020.040.040.02-0.013-0.13-0.17-0.13-0.17-0.23-0.12-0.13-0.24-0.21-0.26-0.39-0.48-0.42-0.39-0.31-0.36-0.32-0.32-0.25-1.71-1.5
EPS Diluted -0.31-0.36-0.44-0.46-0.54-0.5-0.36-0.25-0.23-0.045-0.25-0.13-0.14-0.040.040.090.020.040.040.02-0.013-0.13-0.17-0.13-0.17-0.23-0.12-0.13-0.24-0.21-0.26-0.39-0.48-0.42-0.39-0.31-0.36-0.32-0.32-0.25-1.71-1.5
EBITDA -30.749-38.705-4.544-55.442-59.939-60.249-42.978-21.952-18.4741.804-23.398-5.818-9.8152.28212.09217.219.269-1.4930.1525.7871.196-4.189-8.664-2.935-4.798-10.474-4.506-3.866-13.719-11.713-17.878-26.712-35.83-30.835-30.236-24.238-26.618-21.422-22.614-17.395-20.751-17.528
EBITDA Ratio -0.205-0.279-0.034-0.435-0.476-0.493-0.335-0.168-0.1310.013-0.176-0.044-0.0740.0170.0840.130.08-0.0150.0020.0630.014-0.057-0.124-0.045-0.078-0.201-0.084-0.077-0.357-0.336-0.591-1.232-2-2.362-2.442-2.707-4.068-4.113-5.949-3.977-5.034-5.49